Eisai Inc., a Woodcliff Lake-based pharmaceutical subsidiary of Eisai Co. Ltd., announced Tuesday it has appointed Patrick Coyle as vice president and chief financial officer.
In this role, Coyle, who will serve on Eisai’s executive committee, will be responsible for overseeing the company’s financial operations in the U.S. and Canada.
Coyle, who has more than two decades of experience in financial planning and analysis, operations and strategy development, most recently served as vice president, financial planning and analysis at INSMED Inc. Previously, he held roles of increasing responsibility in the finance departments at Novartis, Bayer HealthCare Pharmaceuticals, Sun Chemical and Computer Horizons Corp.
“Patrick joins Eisai at an extraordinary time in our company’s evolution as we deepen our commitment and investments in oncology and neurology,” Shaji Procida, president and chief operating officer at Eisai Inc., said. “As part of our executive team, his diverse financial background, strategic vision and proven leadership will be invaluable as we continue our relentless efforts to ensure we are breaking through to find innovative solutions and medicines to maximize the potential benefits for more patients.”
